News

Philanthropy-Backed Accelerator Advances Cancer Therapies
Three teams receive awards from the Dartmouth Innovations Accelerator for Cancer

NH Cancer Researchers Find Cellular Evidence Behind Lasting Immune Response in Some Cancer Survivors
Researchers have found that a certain subpopulation of cells that enters a patient’s skin and blood during immunotherapy is behind the excellent and long-lasting immune responses to cancer that some survivors develop.

COVID-19 and Cancer: D-H Doctors Discuss Vaccine Safety for Cancer Patients on “The Cure Podcast”
Special guest, DHMC Interim Section Chief of Medical Oncology Gary N. Schwartz, MD.

Seeing the Invisible: NCCC Pioneers Radiation Vision Cameras
Cherenkov imaging cameras invented by Dartmouth spinoff company and pioneered at NCCC allow radiation oncologists to visualize external beam field, improving quality, precision and patient safety during radiation therapy.

Gifts Totaling $3.35 Million will Fuel Cancer Research in New Hampshire
A Dartmouth faculty member, a husband grateful for the care his wife received, and a Dartmouth College alumna and her husband have made gifts to accelerate immunotherapy research at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center.

Cancer Doesn’t Stop for COVID-19: Dartmouth-Hitchcock’s Norris Cotton Cancer Center Joins Nationwide Effort to Resume Cancer Screening
“Cancer did not pause for COVID-19 and neither did we,” says NCCC director Steven D. Leach, MD

Cancer Care Close to Home: New Hampshire’s Only NCI-Designated Comprehensive Cancer Center Expands Cancer Services in Southern New Hampshire
Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center will open two new specialty clinics, NeuroOncology and Gynecologic Oncology, at their Dartmouth-Hitchcock location at the Catholic Medical Center’s Notre Dame Pavilion in Manchester.

COVID-19 Vaccine FAQ for Norris Cotton Cancer Center Patients
Read answers to frequently asked questions related to the safety and efficacy of the COVID-19 vaccine for patients undergoing treatment for cancer.

Lionel D. Lewis, MD, Elected as a 2020 Fellow of the British Pharmacological Society
Dr. Lewis elected for prestigious fellowship for his substantial contributions, demonstrated distinction, and peer recognition in clinical pharmacology and therapeutics.